Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Capital Expenditures (2020 - 2025)

Historic Capital Expenditures for Benitec Biopharma (BNTC) over the last 5 years, with Q1 2025 value amounting to $6000.0.

  • Benitec Biopharma's Capital Expenditures changed N/A to $6000.0 in Q1 2025 from the same period last year, while for Jun 2025 it was $7000.0, marking a year-over-year decrease of 5000.0%. This contributed to the annual value of $18000.0 for FY2025, which is 8994.41% down from last year.
  • Benitec Biopharma's Capital Expenditures amounted to $6000.0 in Q1 2025.
  • Benitec Biopharma's 5-year Capital Expenditures high stood at $15000.0 for Q1 2021, and its period low was -$141000.0 during Q2 2021.
  • In the last 4 years, Benitec Biopharma's Capital Expenditures had a median value of $6000.0 in 2025 and averaged -$21200.0.
  • Its Capital Expenditures has fluctuated over the past 5 years, first plummeted by 118461.54% in 2021, then skyrocketed by 10921.99% in 2022.
  • Over the past 4 years, Benitec Biopharma's Capital Expenditures (Quarter) stood at -$141000.0 in 2021, then skyrocketed by 109.22% to $13000.0 in 2022, then crashed by 92.31% to $1000.0 in 2023, then skyrocketed by 500.0% to $6000.0 in 2025.
  • Its Capital Expenditures was $6000.0 in Q1 2025, compared to $1000.0 in Q2 2023 and $13000.0 in Q2 2022.